发布求助

文献互助智能选刊最新文献

Neoplasia

SCI期刊

查看最新文献

1686

中科院SCI期刊分区 WOS期刊分区历年影响因子历年发表同类期刊

中文名称：

瘤形成

期刊缩写：

NEOPLASIA

影响因子：

6.3

ISSN：

print: 1476-5586
on-line: 1522-8002

研究领域：

ONCOLOGY

h-index：

115

自引率：

2.10%

Gold OA文章占比：

98.62%

原创研究文献占比：

93.62%

SCI收录类型：

Science Citation Index Expanded (SCIE) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)

期刊官网：

http://www.neoplasia.com/ https://www.journals.elsevier.com/neoplasia

期刊介绍英文：

Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.

发文信息

中科院SCI期刊分区

大类	小类	TOP期刊	综述期刊
2区医学	2区肿瘤学 ONCOLOGY	否	否

WOS期刊分区

学科分类
Q1ONCOLOGY

历年影响因子

2017年	4.5090
2018年	5.0060
2019年	4.9940
2020年	3.8370
2021年	5.7150
2022年	4.8000
2023年	6.3000

历年发表

2012年	121
2013年	135
2014年	113
2015年	95
2016年	85
2017年	104
2018年	112
2019年	100
2020年	75
2021年	117
2022年	82

投稿信息

出版语言：

English

出版国家(地区)：

UNITED STATES

投稿网址：

https://www.editorialmanager.com/NEO

出版商：

Neoplasia Press

编辑部地址：

STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169

PubMed链接：

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-5586%5BISSN%5D

Neoplasia - 最新文献

Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer.

Pub Date : 2024-11-18 DOI: 10.1016/j.neo.2024.101077 Qiao-Xin Lin, Wen-Wen Song, Wen-Xia Xie, Yi-Ting Deng, Yan-Na Gong, Yi-Ru Liu, Yi Tian, Wen-Ya Zhao, Ling Tian, Dian-Na Gu

DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway.

Pub Date : 2020-08-01 DOI: 10.21203/rs.3.rs-48447/v1 Shuaikang Chang, Bo Li, Yongsheng Xie, Yingcong Wang, Zhijian Xu, Shuhan Jin, D. Yu, Huaping Wang, Yumeng Lu, Yong Zhang, Ruye Ma, Cheng Huang, Weiming Lai, Xiaosong Wu, Weiliang Zhu, Jumei Shi

Corrigendum to "Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile." Neoplasia 2009, Feb;11(2):167-176.

Pub Date : 2018-01-28 DOI: 10.1016/J.NEO.2017.11.008 J. Gibcus, L. Tan, G. Harms, R. Schakel, D. de Jong, T. Blokzijl, P. Möller, S. Poppema, B. Kroesen, A. van den Berg

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。